EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitUmbrella ReviewOpen Access

Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review

Edward Jeong, Dan Li

Cureus · 24.09.2025

DOI: 10.7759/cureus.93140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 24.09.2025. Verfasst von Edward Jeong und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Choate Rosemary Hall, Farmington, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, is a fatal neurodegenerative disease prominent in the elderly population. To this point, no completely effective treatments have been procured; however, antisense oligonucleotide therapies, or ASOs, are a promising venue. In order to investigate the efficacy of ASOs in the treatment of ALS by targeting specific genetic mutations, we conducted an umbrella review utilizing keywords such as "ALS" and "ASO" in the PubMed database, excluding sources published more than 10 years ago for relevance. Results revealed that of multiple tentative ASO treatments, for multiple specific gene mutations, only one, Tofersen, was approved for the wider population. The main cause of failure was an inability to meet efficacy endpoints, resulting in the discontinuation of the product. Tofersen is able to treat mutations in the SOD1 gene, but not any others. While initially discouraging, the production of ASOs is a relatively new and advanced process, and slow progress is expected. However, there remains the problem of identifying and treating the much more prevalent sporadic ALS, which is much more common compared to familial ALS.

Schlagwörter

Stichwörter der Autor:innen

als treatmentantisense oligonucleotide therapyantisense oligonucleotidesfamilial amyotrophic lateral sclerosisneurodegenerative disease

Autor:innen und Institutionen

  • College of Medicine, Choate Rosemary Hall, Farmington, USA.
  • General Medicine, Massachusetts General Hospital, Boston, USA.

Zitieren

APA

Jeong, E., & Li, D. (2025). Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review. Cureus. https://doi.org/10.7759/cureus.93140

Vancouver

Jeong E, Li D. Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review. Cureus. 2025. doi:10.7759/cureus.93140

BibTeX
@article{Jeong2025,
  author = {Jeong, Edward and Li, Dan},
  title = {Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review},
  journal = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.93140}
}
Kostenlos starten →